Robust mechanisms stressed to oversee private hospitals
The committee held comprehensive discussions on a broad range of topics, including the regulation of private hospitals, healthcare standards and the functionality of key health institutions.
The committee reviewed the Islamabad Healthcare Regulatory Authority (IHRA)'s progress and stressed the need for robust mechanisms to oversee private hospitals.
Members expressed concerns about unchecked pricing practices and called for collaboration with provincial healthcare commissions, particularly Punjab's, to establish effective pricing frameworks.
The IHRA was directed to provide a complete list of private hospitals, details of regulations and an update on inquiries into specific cases.
Addressing accountability, the committee emphasised the need for audits and performance checks for hospitals operating on government-allocated plots.
A sub-committee was constituted under the convenor-ship of Dr Amjad Ali Khan with Sabheen Ghoury, Dr Shazia Sobia Aslam Soomro and Dr Shaista Khan, as its members to examine gaps in IHRA's regulatory framework and oversee agreements with private hospitals to ensure compliance with welfare service obligations.
The National Institute of Rehabilitation Medicine (NIRM) presented an overview of its services and challenges, highlighting the need for enhanced infrastructure and resources.
Members praised the institute's contributions but raised concerns about hygiene, doctor attendance and patient care.
The committee recommended measures to address staffing gaps, improve facility cleanliness and ensure equitable distribution of medical resources.
On legislative matters, the committee deferred discussions on 'The Pharmacy (Amendment) Bill, 2024' (moved by Abdul Qadir Patel), citing the absence of the minister in charge.
However, members agreed to move forward with the deliberations in the next meeting.
The mover authorised Dr Shazia Sobia Aslam Soomro, to present the bill on his behalf. A discussion would then ensue to decide the bill's fate.
Significant discussions were held on combating polio and ensuring stringent quality control for pharmaceutical products.
Members also addressed discrepancies in the allocation of budgets and emphasised the need for thorough audits and reports on resource utilisation.
The chair commended the progress made while underscoring the importance of timely actions and accountability.
The meeting concluded with a commitment to advancing healthcare reforms and ensuring that public health services meet the highest standards of care and regulation.
Copyright Business Recorder, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
3 days ago
- Business Recorder
Non-essential drugs: Medicines widely available after deregulation
KARACHI: Nearly all medicines required by Pakistani patients are now widely available at local pharmacies, following the government's move to deregulate prices of non-essential drugs, industry representative said. Officials, pharmaceutical industry representatives, and health experts say the decision has effectively ended years of chronic shortages and curbed black-market profiteering. They said the policy shift has restored patient access to life-saving treatments, reduced counterfeit drugs, and revived confidence in the pharmaceutical supply chain. Pharmaceutical manufacturers, speaking to journalists in Karachi, said deregulation reversed a crisis that had left patients scrambling for basic and critical medicines. 'For a long time, essential drugs like insulin, tuberculosis treatments, and even over-the-counter painkillers such as Panadol were missing from pharmacies because their government-fixed prices were far below production cost,' said Pakistan Pharmaceutical Manufactur-ers Association (PPMA) Chairman Tauqeer ul Haq. He explained that with inflation, currency devaluation, and rising global raw material costs, production at the old rates became impossible. 'A tablet that cost Rs 3 to the patient couldn't be manufactured even at that price. Deregulation allowed the same tablet to be priced at Rs. 6, which brought it back to the market,' he said. Health experts also endorsed the change, saying it reduced black-market exploitation and improved the supply of quality medicines. Deregulation, introduced at the end of 2023, applies only to non-essential medicines, while more than 460 essential drugs remain under strict government price control to safeguard affordability. Even provincial drug administration officials across all four provinces and federally administered regions confirmed that nearly all medicines are now available in the market. They said shortages that previously created space for counterfeit products have largely been eliminated. A joint survey by PPMA and Pharma Bureau, supported by a recent IQVIA report, found that post-deregulation prices for the top 100 pharmaceutical brands increased by an average of 16.5 percent. Industry officials clarified, however, that much of this rise came from prior hardship price adjustments and new product introductions rather than deregulation alone. According to the Pakistan Bureau of Statistics, the Consumer Price Index for medicines in June 2025 showed urban prices rising by 13.05 percent and rural prices by 15.3 perent—still lower than inflation in many other sectors. Officials highlighted that previously scarce drugs, including anti-epileptics, psychiatric medicines, and certain cancer therapies, are now widely available. Unit sales of medicines have also improved, with IQVIA reporting a rise in market volume growth from 0.8 percent in 2023 to 3.6 percent this year. Copyright Business Recorder, 2025
Business Recorder
4 days ago
- Business Recorder
Health projects: Punjab introduces new monitoring system
LAHORE: In line with the vision of Punjab Chief Minister Maryam Nawaz Sharif, the Department of Health and Population has introduced a robust and centralized monitoring system to ensure transparent, accountable and timely execution of health-related development projects across the province. Going forward, all health sector initiatives will be monitored and evaluated through the department's Monitoring and Evaluation Directorate, which will track project implementation, assess performance, and ensure alignment with provincial health priorities. A high-level meeting, chaired by Provincial Minister for Health and Population Khawaja Imran Nazir was held at the department's headquarters. The meeting was attended by Chief Secretary Punjab Zahid Akhtar Zaman, Chairman Planning and Development Board Naeem Rauf, Secretary Health and Population Nadia Saqib, and other senior officials. To ensure uninterrupted oxygen supply at public hospitals, the meeting decided to establish 13 new oxygen feeders. This move will support 145 district and tehsil headquarters hospitals (DHQs and THQs), enabling them to receive over 44,000 oxygen cylinders per month, thus enhancing emergency and critical care capacity across Punjab. Khawaja Imran Nazir directed all vertical programs to submit detailed annual performance reports. He emphasized that as per the Chief Minister's instructions, routine and rigorous evaluations would be conducted to assess progress and impact. He reaffirmed the provincial leadership's commitment to healthcare reform, stating: 'Providing quality healthcare at the doorstep of every citizen is Chief Minister Maryam Nawaz Sharif's foremost priority.' The minister also highlighted that the revamping of more than 4,000 health facilities is underway and progressing at a steady pace. Chief Secretary Punjab Zahid Akhtar Zaman stressed the importance of effective monitoring mechanisms to ensure timely completion and quality delivery of health projects. He reiterated that reform efforts in the healthcare system are ongoing and that the Monitoring and Evaluation Directorate would be further strengthened for improved oversight. He also issued directives for the verification of household registration data under the Community Health Inspector Program, calling for greater data integrity and on-ground accountability. The meeting reviewed progress on several flagship initiatives, including Maryam Nawaz Health Clinics, Community Health Inspector Program, establishment of blood centers in Lahore, Okara, Muzaffargarh, and Jhelum and setting up of Cath labs in Attock, Jhang, Jhelum, Layyah, Mianwali, Kasur, Vehari, and Bahawalnagar. The officials briefed that the Community Health Inspector Program is being implemented in two phases, with the geo-tagging of over 530,000 households already completed in the first phase. Copyright Business Recorder, 2025
Business Recorder
5 days ago
- Business Recorder
Highnoon forges alliance with BD's Beximco
KARACHI: Highnoon Laboratories Limited, a prominent Pakistani pharmaceutical company, announces a significant strategic partnership with Beximco Pharmaceuticals Limited, a leading pharmaceutical firm based in Bangladesh. The collaboration aims to enhance the availability of specialised pharmaceutical products in Pakistan, focusing on critical therapeutic areas such as respiratory, diabetes, and cardiovascular diseases. The partnership was formalised through the signing of a Memorandum of Understanding (MoU) between the two companies. This alliance is set to introduce newer therapies, advanced dosage forms, and innovative drug delivery systems to the Pakistani market, promising improved ease of use and better clinical outcomes for patients, while simultaneously enhancing access to advanced medications. Beximco Pharmaceuti-cals Limited brings to the table state-of-the-art manufacturing facilities, which have received accreditation from stringent regulatory authorities across the globe, including the USA, Australia, the European Union, Canada, and Brazil. This robust accreditation underscores Beximco's commitment to quality and international standards. Highnoon Laboratories Limited, recognised as a recipient of Forbes Asia's 'Best Under A Billion' award in 2023, views this strategic alliance as a pivotal step. According to the disclosure made to the Pakistan Stock Exchange Limited, the company believes this partnership will not only benefit patients in Pakistan but also significantly contribute to the ongoing expansion of trade relations and economic cooperation between Pakistan and Bangladesh. The collaboration is expected to bring substantial advancements to Pakistan's healthcare sector, offering new hope and improved treatment options for patients suffering from high-burden diseases. Copyright Business Recorder, 2025
